exam 3 Flashcards
opioids are classified as
narcotic analgesics (pain relieving drug)
narcotic analgesics
- produce pain without unconsciouness
- produces relaxation/sleep state
- produces state of euphora (not usually thru oral)
- high doses causes respiratory depression
How are the narcotic analgesics made?; Opium, Opiate and Opioid
Opium - extract from poppy plant; morphine
Opiate - derived from poppy plant; morphin e
Opioid
- naturally derived molecules (morphine)
- semi-synthetics (heroin)
-synthetics molecules (fentanyl)
- endongonous peptides (endorphins)
Heroin
- more potent than morphine (2-4x) through IV
- equipotent (produce same effect, but at different doses) when taken orally
4 aspects of opioid intoxication
- rush
- high
- nod
- being straight
adverse effects of opioids
- vomiting
- high doses effects (lethality)
- constipation (oic)
opioid subtypes
mu, delta, kappa and NOP-R
all opioid receptors are gpcrss
mu receptor
seems to be major subtype that produces analgesic effects, euphoria, addicition and respiratory addiction
mu receptor KO mice
- do not self administer
- do not exhibit conditioned place prefernce (where they receive the drug)
- no dependence on drug after chronic use
- no side effects of constipation, respiratory depression or analgesia
location of mu receptors (in the brain)
- expressed in analgesic area of the brain
- positive reinforment
- cough supressants, respiratory/cardiovascular depression, nausea, vomiting
how opioids mediate effects
- postsynaptic inhibition
- axoaxonic inhibition
- presynapic autoreceptors
opioids and pain
pain is subjective, varies in intensity and quality
first/early pain (immediate); Adelta fibers, large, myelinated, fast
second/late pain (dull, chronic); C fibers, thin, unmyleniated
how opioid drugs mediate pain
- within spinal cord
- descending pathways from PAG (brain to spinal cord)
- higher brain sites (reducing emotional responses to pain)
PAG and descending in modulation
-PAG is key to descending pain inhibition
-stimulating PAG created analgesic effect but tolerance develops
- IV morphine did not help, as cross-tolerance develops too
GABAergic interneurons
GABAergic interneurons in the PAG normally inhibit descending pain-control neurons by releasing GABA, which acts as a “brake.”
Opioid Effect:
Opioids bind to μ-receptors on these GABA neurons and inhibit the inhibitor → lifting the brake → activating descending pain relief pathways.
reinforcement + tolerance+ dependence
Mesolimbic DA pathway:
- injecting opioid causes stopping the GABAbrake, which causes feel goods (dopamine) to flood the nucleaus Accumbens
reinforcing properties
lowers icss threshold
severity of withdrawal
- vary with paritculsr drug
- heroin (iv); 2-4 days after use
- complete in 7-10 days
- methadone: agonist of mu opioid receptor
withdrawal = rebound hyperactivity
Medication-Assisted Treatment (MAT) for opioid use disorder
- best approach for opioid use
Drugs: FDA approved
-methadone (opioid) - buprenorphine (opioid)
- naltrexone
Methadone maintenance therapy
- given orally (not producing euphoria) but actiavtes just enough for them to operate in society
- cross dependenace with heroin: prevents severe withdrawal symptoms
- cross-tolerance: chronic methadone exposure, euphora of heroin is reduced
Buprenorphine
- orally or dissolving strips
- longer duration
- lower risk of overdose
Suboxone
-Buprenorphine and naloxone (opioid antagonist)
- when taken orally the Buprenorphine is absorbed, naloxone is not
but taken through IV, the naloxone (Narcan) will be activated and cause severe withdrawal
Naltrexone (vivitrol)
- longer duration than naloxone
- effective when taken orally
- highly motivated individuals
Psychomotor stimulants
increase motor activity and produce euphoria.